iRhythm Holdings (IRTC) EBT Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 1,219.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,219.00 |
| Dec 31, 2025 | 360.00 |
| Sep 30, 2025 | 2,848.00 |
| Jun 30, 2025 | 574.00 |
| Mar 31, 2025 | 1,566.00 |
| Dec 31, 2024 | 2,829.00 |
| Sep 30, 2024 | -957.00 |
| Jun 30, 2024 | 127.00 |
| Mar 31, 2024 | 43.00 |
| Dec 31, 2023 | -1,114.00 |
| Sep 30, 2023 | -107.00 |
| Jun 30, 2023 | 867.00 |
| Mar 31, 2023 | 1,972.00 |
| Dec 31, 2022 | 2,178.00 |
| Sep 30, 2022 | 713.00 |
| Jun 30, 2022 | -217.00 |
| Mar 31, 2022 | -1,748.00 |
| Dec 31, 2021 | -2,737.00 |
| Sep 30, 2021 | -2,131.00 |
| Jun 30, 2021 | 1,870.00 |
| Mar 31, 2021 | -2,301.00 |
| Dec 31, 2020 | 1,696.00 |
| Sep 30, 2020 | 2,707.00 |
| Jun 30, 2020 | -1,949.00 |
| Mar 31, 2020 | 280.00 |
| Dec 31, 2019 | 959.00 |
| Sep 30, 2019 | -812.00 |
| Jun 30, 2019 | 1,416.00 |
| Mar 31, 2019 | 1,796.00 |
| Dec 31, 2018 | 306.00 |
| Sep 30, 2018 | 204.00 |
| Jun 30, 2018 | -625.00 |
| Mar 31, 2018 | -903.00 |
| Dec 31, 2017 | -1,405.00 |
| Sep 30, 2017 | -664.00 |
| Jun 30, 2017 | 26.00 |
| Mar 31, 2017 | 1,811.00 |
| Dec 31, 2016 | 4,103.00 |
| Sep 30, 2016 | 4,054.00 |